Drug Topics

OCTOBER 4, 2023

Digging deeper into the cause of insomnia and counseling patients on lifestyle changes can help improve their sleep health.

526

526

PharmaVoice

OCTOBER 4, 2023

The FDA wouldn’t review a drug that was 90% effective. In rare diseases, this is too common, said the UltraGenyx CEO and a leading rare disease researcher.

FDA 279

FDA 279

Drug Topics

OCTOBER 4, 2023

Despite a wealth of data proving their efficacy for acute and chronic pain, these products remain underutilized in the United States.

504

504

PharmaVoice

OCTOBER 4, 2023

Judges have found fault with drug manufacturers’ First and Fifth Amendment arguments against the IRA’s drug pricing measures.

279

279

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

OCTOBER 4, 2023

In many industries, tipping is the norm. Pharmacists would just like to receive payment for services rendered.

282

282

Fierce Healthcare

OCTOBER 4, 2023

Nabla, maker of an autonomous clinical AI scribe, has joined forces with Kaiser Permanente to roll out its tool to 10,000 doctors in Northern California. | The AI tool will be available to 10,000 Kaiser Permanente doctors in Northern California across all care settings and specialties.

145

145

STAT

OCTOBER 4, 2023

LONDON — It was when she was 12 that doctors first raised the prospect of a medicine that could transform the disease Stella Pelteki had inherited into an afterthought. Pelteki was born with beta thalassemia, a disorder that inhibits oxygen’s flow through the blood. Ever since she was a few years old, she’d needed frequent blood transfusions.

145

145

Pharmacy Times

OCTOBER 4, 2023

An overview of antidepressant medications and their indications to inform health care professionals of their wide use and to better understand which antidepressant to recommend based on patient-specific characteristics.

132

132

STAT

OCTOBER 4, 2023

Amid the stunning rebuke Amgen suffered at the hands of the U.S. Food and Drug Administration this week lurk numerous questions. And one of them may be whether the company was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth. At issue is a trial that Amgen is relying upon to win final approval for Lumakras, which the FDA approved on a conditional basis in 2021.

Documentation 137

Documentation FDA 137

Fierce Healthcare

OCTOBER 4, 2023

Women's health needs more innovation and investment, particularly in maternal care. | Research shows that the U.S. is facing a maternal health crisis. Diana Health partners with hospital and health system leadership to restructure their women’s health programs with a clinical redesign of labor and delivery.

Hospitals 131

Hospitals 131

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 4, 2023

LONDON — The 2023 Nobel Prize in chemistry was awarded Wednesday to three scientists for the discovery and synthesis of quantum dots, tiny particles that have fueled innovations in nanotechnology from televisions to mapping different tissues in the body.   The prize went to Moungi Bawendi of MIT, Louis Brus of Columbia University, and Alexei Ekimov, formerly the chief scientist at Nanocrystals Technology in New York.

132

132

Pharmacy Times

OCTOBER 4, 2023

Hispanic individuals have been found to be more likely to develop complications as a result of diabetes compared to those who are non-Hispanic White.

130

130

STAT

OCTOBER 4, 2023

It’s the end of an era for a once-critical pandemic document: The ubiquitous white Covid-19 vaccination cards are being phased out. Now that Covid-19 vaccines are not being distributed by the federal government, the Centers for Disease Control and Prevention has stopped printing new cards.

Vaccines 131

Vaccines Documentation 131

Fierce Healthcare

OCTOBER 4, 2023

WellTheory, a platform focused on reducing autoimmune disease symptoms, has unveiled an enterprise product for employers and payers looking to offer autoimmune care. | The new offering aims to tackle the hidden costs and productivity impacts of untreated autoimmune diseases. It will include a community-based program that gives members access to events, tools, experts and peers for support.

130

130

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmaVoice

OCTOBER 4, 2023

Leaders decoding the complex language of drug development to push treatments past the finish line and into patients’ hands.

130

130

STAT

OCTOBER 4, 2023

An innocuous slip while cutting her toenails created a wound on Cynthia Elford’s right foot that wouldn’t heal. The Hermitage, Pennsylvania resident has vasculitis, a genetic disease that inflames the blood vessels and stops blood from flowing to the legs. She had already lost her left leg below the knee after a sunburn on the tip of her toe got progressively worse.

FDA 128

FDA 128

PharmaVoice

OCTOBER 4, 2023

Leaders innovating new ways to incorporate patient voices in drug development and decrease barriers to access.

130

130

STAT

OCTOBER 4, 2023

Nasal esketamine spray is more effective than an extended-release antipsychotic, when both are taken in combination with SSRIs and SNRIs, in patients with depressive episodes that didn’t respond to two or more consecutive treatments, according to a study published Wednesday in the New England Journal of Medicine. Research dating back to the early 2000s has shown that ketamine and esketamine — which is derived from ketamine — are effective in cases of so-called treatment-resi

126

126

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Checkup by Singlecare

OCTOBER 4, 2023

Managing your weight can be challenging, which is why many people look for relatively quick and easy ways to drop some pounds. That’s why you may have seen people talk about a medication called Vyvanse, which is FDA approved to treat ADHD and binge eating disorder, as a good option for weight loss. The reality, though, is that while weight loss can be a side effect of taking Vyvanse, the drug should not be used for the sole purpose of losing weight.

Labelling 125

Labelling FDA Controlled Substances Hospitals 125

Pharmacy Times

OCTOBER 4, 2023

The use of nirmatrelvir or molnupiravir can aid treatment for individuals that are at high risk of developing severe COVID-19, regardless of varying demographics.

123

123

pharmaphorum

OCTOBER 4, 2023

Oncology in the NHS: Situations, challenges, and solutions Mike.

119

119

Pharmacy Times

OCTOBER 4, 2023

Laura Akers, PharmD, RPh/CPh, MBA, BCOP discusses the role of the pharmacist, how the pharmacy profession has changed, and what is to come in the field.

123

123

pharmaphorum

OCTOBER 4, 2023

Navigating EAPs: Clinical trials and the path to investigational drugs Mike.

119

119

Fierce Healthcare

OCTOBER 4, 2023

Mental health provider Brightside Health is partnering with Centene, Optum, Lucet, Blue Cross and Blue Shield of Texas and other payers to serve 50 million people in Medicare and Medicaid. | Brightside Health announced expanded partnerships with major health payers including Centene, Optum and Lucet on Thursday.

118

118

pharmaphorum

OCTOBER 4, 2023

Sandoz separates from Novartis, valued at just over $11bn Phil.

119

119

STAT

OCTOBER 4, 2023

WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT. The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase.

Hospitals 117

Hospitals Insurance 117

Drug Store News

OCTOBER 4, 2023

Winn-Dixie is kicking off a a community donation program to support neighbors impacted by breast cancer.

111

111

Fierce Healthcare

OCTOBER 4, 2023

More than half of therapists report experiencing burnout this year, a new survey has found. | At a time when Americans are increasingly seeking mental health treatment and there is a behavioral health workforce shortage, three-quarters of respondents who have experienced burnout say they are hesitant to take on more acute patients.

111

111

Med Ed 101

OCTOBER 4, 2023

It’s hard to believe that I have been following pharmacist board certifications and helping pharmacists pass the BCPS exam for over 10 years since I first passed it in 2013! Each year in updating and creating our study materials, I review the content outline and any possible changes in the BCPS exam. There are definitely […] The post 2024 BCPS Exam – What’s Changing?

111

111

Fierce Healthcare

OCTOBER 4, 2023

Minnesota Attorney General Keith Ellison announced Tuesday that he is reviewing two pending health system mergers under a recently passed state law that gave his office additional authority to dete | The Froedtert Health-ThedaCare and St. Luke's Duluth-Aspirus Health merger deals announced earlier this year will be subject to Minnesota Attorney General Keith Ellison's newly granted oversight authority.

111

111

pharmaphorum

OCTOBER 4, 2023

Lilly takes POINT in radiopharma push Phil.

110

110

STAT

OCTOBER 4, 2023

Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? After all, you made it this far, which is a likely sign of surviving another few days. And of course, no prescription is required, which is a good thing. Our choice today is butter pecan.

FDA 107

FDA Labelling 107

Drug Store News

OCTOBER 4, 2023

Xiromed's EnilloRing is a contraceptive vaginal ring.

106

106